3rd Quarter - Report

TIBER CREEK GROUP for VERTEX PHARMACEUTICALS

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to drug pricing; Issues related to H.R. 1227/S. 475 - Alternatives to PAIN Act.

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ —
JONATHON JONES —
EMILY KIRLIN —
COREY MALMGREN —
SEAN RICHARDSON —

Contacted: SENATE; Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES

Bills named: S. 475 (119th), H.R. 1227 (119th)

Defense DEF

Issues related to opioid alternatives; Issues related to H.R. 3838 - Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026; Issues related to S. 2296 - National Defense Authorization Act for Fiscal Year 2026.

LobbyistCovered position, as disclosed
EMILY KIRLIN —
SEAN RICHARDSON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 2296 (119th), H.R. 3838 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.